普洛药业:司美格鲁肽项目Ⅲ期临床试验已全部入组完成
Core Viewpoint - The company has completed the enrollment for the phase III clinical trials of its semaglutide project, which targets both weight loss and diabetes management, and is currently in the follow-up phase of administration [1] Group 1 - The semaglutide project includes indications for both weight loss and diabetes [1] - All participants have been enrolled in the phase III clinical trials [1] - The current stage of the project involves follow-up after administration [1]